Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Alisha Kimble
Advertisement
Alisha Kimble is a senior outcomes researcher at Ontada.
Articles by Alisha Kimble
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
An Overview of Pancreatic Neuroendocrine Tumors (PNETs)
2
Kidney Cancer Disparities Persist Among American Indian and Alaskan Native Patients
3
Higher BMI Linked to Better Survival in Localized Kidney Cancer
4
Osteosarcoma Guide: Stages, Treatment, Side Effects and Patient Journey
5
